mogamulizumab for patients with ctcl
Published 2 years ago • 312 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
1:12
mogamulizumab-associated rash in patients with ctcl
-
0:40
mavoric: long-term clinical benefit of mogamulizumab in patients with ctcl
-
0:38
link between blood involvement and hrqol in ctcl patients receiving mogamulizumab
-
0:54
mogamulizumab-associated rash in ctcl
-
2:54
ck0804, a cord blood-derived cellular therapy, in myelofibrosis with suboptimal ruxolitinib response
-
2:50
cutaneous t-cell lymphoma - yale medicine explains
-
7:49
mycosis fungoides (cutaneous t-cell lymphoma): 5-minute pathology pearls
-
2:31
mavoric trial: mogamulizumab for r/r ctc
-
1:46
methods to access the clinical efficacy of mogamulizumab
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
0:58
mogamulizumab: an exciting antibody for autoimmunity
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:13
novel therapies on the horizon for ctcl
-
1:30
clinical trial updates for ctcl: argx-110 and mogamulizumab
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
2:05
novel therapies on the horizon for cutaneous t-cell lymphoma
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:36
safety and preliminary efficacy of elotuzumab and belantamab mafodotin in patients with r/r myeloma
-
1:56
overview of the clinical management of patients with mf
-
5:21
chemo-free regimens in lymphoma